Autoimmune Myocarditis and Arrhythmogenic Mitral Valve Prolapse: An Unexpected Overlap Syndrome

Background: both myocarditis and mitral valve prolapse (MVP) are known uncommon causes of ventricular arrhythmias in young patients. Aim: to report the first clinical case of endomyocardial biopsy (EMB)-proven autoimmune myocarditis and associated arrhythmogenic MVP in a patient with recurrent ventricular fibrillation (VF) episodes. Methods: myocarditis was diagnosed both by cardiac magnetic resonance (CMR) and EMB. Arrhythmogenic MVP was documented by transthoracic echocardiogram, CMR, and electroanatomical mapping of the trigger premature ventricular contractions (PVCs). Results: a 22-year-old woman underwent immunosuppressive therapy after EMB-proven diagnosis of autoimmune myocarditis with VF onset and early implantable cardioverter defibrillator (ICD) placement. Three years later, she experienced two VF recurrences and persistent PVCs, despite no signs of myocarditis recurrence. An echocardiogram revealed bileaflet MVP with high arrhythmic risk features. Finally, electroanatomical mapping and ablation of the trigger PVC were successfully performed. Conclusion: in patients with recurrent VF episodes despite evidence-based medical treatment for myocarditis, MVP should be considered as an alternative arrhythmogenic substrate, and warrants early ICD implant and PVC-targeted therapy.

[1]  S. Rizzo,et al.  Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy , 2020, Pacing and clinical electrophysiology : PACE.

[2]  S. Heymans,et al.  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions , 2020, Nature Reviews Cardiology.

[3]  S. Rizzo,et al.  Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis. , 2020, Journal of the American College of Cardiology.

[4]  C. Campochiaro,et al.  Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic , 2020, American Heart Journal.

[5]  S. Rizzo,et al.  Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias. , 2020, JACC. Clinical electrophysiology.

[6]  C. Campochiaro,et al.  Therapeutic strategies for virus-negative myocarditis: a comprehensive review. , 2020, European journal of internal medicine.

[7]  S. Rizzo,et al.  Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. , 2020, Journal of the American College of Cardiology.

[8]  B. Maisch,et al.  Inflammatory dilated cardiomyopathy , 2020, Herz.

[9]  P. Della Bella,et al.  [Diagnostic and therapeutic approach to myocarditis patients presenting with arrhythmias]. , 2020, Giornale italiano di cardiologia.

[10]  C. Basso,et al.  Programmed ventricular stimulation in patients with active vs previous arrhythmic myocarditis , 2020, Journal of cardiovascular electrophysiology.

[11]  S. Iliceto,et al.  Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death. , 2019, Circulation.

[12]  Narayanan Namboodiri,et al.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  Corrigendum to: 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  M. Chung,et al.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias , 2019, Journal of arrhythmia.

[15]  S. Rizzo,et al.  Arrhythmias in myocarditis: State of the art. , 2019, Heart rhythm.

[16]  S. Rizzo,et al.  Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis. , 2019, International journal of cardiology.

[17]  D. Adams,et al.  Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[18]  T. Helle-Valle,et al.  The Mitral Annulus Disjunction Arrhythmic Syndrome. , 2018, Journal of the American College of Cardiology.

[19]  William J. Bryant,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2018, Circulation.

[20]  M. Russo,et al.  Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy , 2018, Journal of the American Heart Association.

[21]  William J. Bryant,et al.  2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Heart rhythm.

[22]  A. Tajik,et al.  The Pickelhaube Sign: Novel Echocardiographic Risk Marker for Malignant Mitral Valve Prolapse Syndrome. , 2017, JACC. Cardiovascular imaging.

[23]  R. Wojnicz,et al.  Suspicion of myocarditis in a patient with mitral valve prolapse. , 2017, Polish archives of internal medicine.

[24]  P. Noseworthy,et al.  Sites of Successful Ventricular Fibrillation Ablation in Bileaflet Mitral Valve Prolapse Syndrome , 2016, Circulation. Arrhythmia and electrophysiology.

[25]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[26]  S. Markowitz,et al.  Differentiation of Papillary Muscle From Fascicular and Mitral Annular Ventricular Arrhythmias in Patients With and Without Structural Heart Disease , 2015, Circulation. Arrhythmia and electrophysiology.

[27]  J. Burkhardt,et al.  Ventricular Fibrillation Triggered by PVCs from Papillary Muscles: Clinical Features and Ablation , 2014, Journal of cardiovascular electrophysiology.

[28]  D. Lin,et al.  Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers. , 2014, Heart rhythm.

[29]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[30]  M. Enriquez-Sarano,et al.  Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. , 2013, Journal of the American College of Cardiology.

[31]  A. Angelini,et al.  Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis , 2010, Heart.

[32]  Andrea Frustaci,et al.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. , 2009, European heart journal.

[33]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[34]  A. Angelini,et al.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.